Novartis acquires Selexys in deal worth up to $665m https://t.co/tgXezGdVVs via @FT
— The Propell Group (@ThePropellGroup) November 21, 2016
#healthtech
Novartis acquires Selexys in deal worth up to $665m https://t.co/tgXezGdVVs via @FT
— The Propell Group (@ThePropellGroup) November 21, 2016
#healthtech